Skip to content

Topical Dexamethasone Versus Topical Lidocaine Spray to Reduce POST in Shoulder Arthroscopic Surgeries: A Comparative Study

Topical Dexamethasone Versus Topical Lidocaine Spray to Reduce Post-intubation Sore Throat in Shoulder Arthroscopic Surgeries: A Comparative Study

Status
Recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06266481
Acronym
post
Enrollment
100
Registered
2024-02-20
Start date
2024-03-01
Completion date
2024-05-30
Last updated
2024-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Sore Throat

Keywords

Sore-throat postoperative, dexamesthsone, 10% lidocaine

Brief summary

postoperative sore throat is the most frequent side effects after anaesthesia intubation. Dexamethasone and 10% lidocaine spray used prior to surgery has shown useful in managing these complications at the moment. In order to examine the prophylactic impact of local Dexamethasone and lidocaine on postoperative sore throat, this study was conducted.

Detailed description

postoperative sore throat is the most frequent side effects after anaesthesia intubation. Dexamethasone and 10% lidocaine spray used prior to surgery has shown useful in managing these complications at the moment. In order to examine the prophylactic impact of local Dexamethasone and lidocaine on postoperative sore throat, this study was conducted.In this study, 100 patients were intubated to undergo general anaesthesia for shoulder arthroscopy and randomised into one of two groups. An endotracheal tube was soaked in 8mg of dexamethasone for the first group intubation, while 10% lidocaine was sprayed over the tube for the second group. Following extubation, the two groups examined the severity of sore throats

Interventions

Patients were interviewed at 1 and 6 h after extubating for post-operative sore throat (POST). POST was assessed by a modified 4-point scale (0= no sore throat, 1= mild sore throat: complains of sore throat only on asking, 2 = moderate sore throat: complains of sore throat spontaneously, and 3 = severe sore throat: change of voice or hoarseness.

DRUG10% lidocaine was sprayed over the tube for the second group

Patients were interviewed at 1 and 6 h after extubating for post-operative sore throat (POST). POST was assessed by a modified 4-point scale (0= no sore throat, 1= mild sore throat: complains of sore throat only on asking, 2 = moderate sore throat: complains of sore throat spontaneously, and 3 = severe sore throat: change of voice or hoarseness.

Sponsors

Pharos University in Alexandria
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* •Patients belonging to ASA physical status I, II * Patients between age18 to 50 years * Patients belonging to both genders. * patients undergoing shoulder arthroscopic surgeries. * Patients with fasting blood glucose <100 mg/dl or random blood sugar <140 mg/dl.

Exclusion criteria

* Patients who are not willing to give consent for participation in the study * Patients with anticipated difficult airway * Patients who are allergic to steroids. * Patients with ASA physical status III, IV * Diabetic patients. * Patients on steroids * Patients requiring nasogastric tube or throat pack. * Patients posted for head and neck surgeries. * patient with GERD * Pregnant patients * preexisting upper respiratory tract infection.

Design outcomes

Primary

MeasureTime frameDescription
Topical dexamethasone versus topical lidocaine spray to reduce post-intubation sore throat in shoulder arthroscopic surgeries: A comparative study3MONTHThis study aimed to compare the effectiveness of topical applications of dexamethasone versus lidocaine spray in prevention sore throat.Patients will be assessed at 1 and 6 h after extubation for post-operative sore throat (POST). POST will be assessed by a modified 4-point scale (0= no sore throat, 1= mild sore throat: complains of sore throat only on asking, 2 = moderate sore throat: complains of sore throat spontaneously, and 3 = severe sore throat: change of voice or hoarseness.

Countries

Egypt

Contacts

Primary ContactMONA el. Mssoud, ph anesthesia
mona.elsaid@pua.edu.eg002+01005542232
Backup Contacthatem a. attallah, ph anesthesia
hatattalla@hotmail.com8000000000

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026